Search

Your search keyword '"Marra A"' showing total 548 results

Search Constraints

Start Over You searched for: Author "Marra A" Remove constraint Author: "Marra A" Journal journal of hepatology Remove constraint Journal: journal of hepatology
548 results on '"Marra A"'

Search Results

1. Agile scores in MASLD and ALD: External validation and their utility in clinical algorithms

2. Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis

3. OS-099-YI Assessment of sarcopenia improves the prediction of post-TIPS mortality in older adult patients with cirrhosis

5. LBP-038 Expanding knowledge regarding real-world treatment of patients with primary biliary cholangitis with obeticholic acid from the Italian RECAPITULATE cohort

6. THU-447 Incidence and predictors of complications following percutaneous liver biopsy: a multicenter study

8. SAT-131 End-procedural complete hemodynamic response may not be essential for the clinical success of tips in patients with cirrhosis

9. THU-093 Biochemical response and liver stiffness variation over time predict liver-related events in patients with primary biliary cholangitis treated with Obeticholic acid

10. THU-492 Prognostic significance of liver decompensation, liver function and portal hypertension in cirrhotic patients with advanced hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab

13. Response to “Hepatic encephalopathy and survival after transjugular intra-hepatic portosystemic shunt: do spontaneous portosystemic shunts matter?”

14. Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis

17. Hepatocyte depletion of ERK5 impairs the response to lipotoxic oxidative stress resulting in defective insulin receptor signaling

18. Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments

20. Relative enhancement and spleen volume predict clinical outcomes in primary sclerosing cholangitis

22. Incidence and risk factors of esophagogastric varices bleeding in patients with advanced hepatocellular carcinoma treated with lenvatinib

24. Presence and severity of esophageal varices drives portal hypertension-related complications in compensated advanced non-alcoholic fatty liver disease

25. Placement of a trans-jugular intrahepatic portosystemic shunt (TIPS) modifies the expression of proinflammatory cytokines in circulating monocytes exposed to lipopolysaccaride

26. Long-term real-world experience with obeticholic acid in primary biliary cholangitis: the Italian recapitulate study

27. Development and validation of a score predicting response to obeticholic acid in primary biliary cholangitis: the OCA response score (ORS)

28. The anti-HIV drug Rilpivirine downregulates migration and proliferation of activated hepatic stellate cells: relevance for the purpose of drug repurposing in liver fibrosis

29. Clinical impact and treatment of veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) after liver transplant (LT): the role of transjugular intrahepatic porto-systemic shunt (TIPS)

31. Metabolic reprogramming in cholangiocarcinoma

32. MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease

33. Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma

34. EASL recommendations on treatment of hepatitis C: Final update of the series☆

39. Transjugular, intra-hepatic portosystemic shunt (TIPS) in elderly patients: preliminary analysis of a multi center retrospective cohort

40. Macrophage MerTK promotes a profibrogenic cross-talk with hepatic stellate cells via soluble mediators

45. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581]

46. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis

48. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

49. Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma

50. Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease

Catalog

Books, media, physical & digital resources